Diana Brainard

CIK: 0001818070

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NKTR

NEKTAR THERAPEUTICS

Director

ALVR

Allovir, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

NKTR
NEKTAR THERAPEUTICS
Sep 23, 2026
Award(A)
Direct
2K shares-
NKTR
NEKTAR THERAPEUTICS
Sep 30, 2025
Award(A)
Stock Option
Direct
8K shares-
ALVR
Allovir, Inc.
Nov 19, 2024
Sale(S)
Direct
8.7K shares at avg. $0.55$5K
ALVR
Allovir, Inc.
Nov 5, 2024
Sale(S)
Direct
10.6K shares at avg. $0.86$9K
ALVR
Allovir, Inc.
Oct 21, 2024
Sale(S)
Direct
9.8K shares at avg. $0.78$8K
ALVR
Allovir, Inc.
Oct 3, 2024
Sale(S)
Direct
1.5K shares at avg. $0.81$1K
NKTR
NEKTAR THERAPEUTICS
Sep 18, 2024
Award(A)
Stock Option
Direct
120K shares-

		Type	Shares	Price		Ownership
Sep 23, 2026	NKTR NEKTAR THERAPEUTICS	Award(A)	2,000	-	$0	Direct
Sep 30, 2025	NKTR NEKTAR THERAPEUTICS	Award(A) Stock Option	8,000	-	-	Direct
Nov 19, 2024	ALVR Allovir, Inc.	Sale(S)	8,706	$0.55	$4,775	Direct
Nov 5, 2024	ALVR Allovir, Inc.	Sale(S)	10,609	$0.86	$9,176	Direct
Oct 21, 2024	ALVR Allovir, Inc.	Sale(S)	9,752	$0.78	$7,597	Direct
Oct 3, 2024	ALVR Allovir, Inc.	Sale(S)	1,493	$0.81	$1,216	Direct
Sep 18, 2024	NKTR NEKTAR THERAPEUTICS	Award(A) Stock Option	120,000	-	-	Direct

1-7 of 7 transactions

About Brainard Diana

Brainard Diana (SEC CIK 0001818070) files insider reports with the SEC as Director of NEKTAR THERAPEUTICS (NKTR) and Chief Executive Officer of Allovir, Inc. (ALVR).

Signal8 holds 7 ownership filings by Brainard Diana (6 Form 4, 1 Form 5), filed between Oct 4, 2024 and Sep 25, 2026. Those filings report 7 transactions, from Sep 18, 2024 to Sep 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brainard Diana's filings is in SAN FRANCISCO, CA.

Recent filings by Brainard Diana

Sep 23, 2026: Grant or award of NKTR shares (Form 4, code A).
Sep 30, 2025: Grant or award of NKTR derivative securities (Form 4, code A).
Nov 19, 2024: Open-market sale of ALVR shares (Form 4, code S).
Nov 5, 2024: Open-market sale of ALVR shares (Form 4, code S).
Oct 21, 2024: Open-market sale of ALVR shares (Form 4, code S).

Other insiders filing for NEKTAR THERAPEUTICS (NKTR)

WHITFIELD ROY A, Director
GREER R SCOTT, Director
CHESS ROBERT, Director
Ajer Jeffrey Robert, Director
Zalevsky Jonathan, Chief R&D Officer
ROBIN HOWARD W, President & CEO

How to read Form 4 transaction codes